ZOM Stock Summary and Trading Ideas (Zomedica Corp. Common Shares | AMEX:ZOM)

Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments namely Diagnostic and Therapeutic Devices. It earns the majority of revenue from the therapeutics segment.

Zomedica Corp. Common Shares trades on the AMEX stock market under the symbol ZOM.

As of February 7, 2025, ZOM stock price was flat at $0.12 with 655,014 million shares trading.

ZOM has a beta of 0.52, meaning it tends to be less sensitive to market movements. ZOM has a correlation of 0.02 to the broad based SPY ETF.

ZOM has a market cap of $117.59 million. This is considered a Micro Cap stock.

In the last 3 years, ZOM traded as high as $.50 and as low as $.12.

The top ETF exchange traded funds that ZOM belongs to (by Net Assets): VTI, VXF.

ZOM has underperformed the market in the last year with a price return of -8.5% while the SPY ETF gained +23.6%. ZOM has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -1.4% and -3.5%, respectively, while the SPY returned +2.4% and -1.1%, respectively.

ZOM support price is $.12 and resistance is $.12 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ZOM shares will trade within this expected range on the day.